check_circleStudy Completed

Contraception, Male

Bayer Identifier:

90851

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Study to assess Norethisterone Enanthate (NET-EN) plus Testosterone Undecanoate (TU) for male contraception

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

N/A

Trial summary

Enrollment Goal
40
Trial Dates
July 2000 - December 2003
Phase
Phase 2
Could I Receive a placebo
N/A
Products
Norethisterone e./Testosterone u. (BAY86-5037)
Accepts Healthy Volunteer
N/A

Primary Outcome

Secondary Outcome

Trial design

Norethisterone enanthate (NET-EN) plus Testosterone undecanoate (TU) for male contraception - a prospective, randomized, 4-arm parallel-group, controlled single-blind study
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.